Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


16.10.2017

1 Ann Surg Oncol
2 Br J Dermatol
1 Cancer
1 Cancer Res
2 J Am Acad Dermatol
2 J Clin Invest
1 J Clin Oncol
3 Melanoma Res
3 Oncogene
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. FARIES MB, Mozzillo N, Kashani-Sabet M, Thompson JF, et al
    Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
    Ann Surg Oncol. 2017 Oct 10. doi: 10.1245/s10434-017-6072.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. BASSOLI S, Kyrgidis A, Ciardo S, Casari A, et al
    Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs.
    Br J Dermatol. 2017 Oct 7. doi: 10.1111/bjd.16030.
    PubMed     Text format     Abstract available

  3. EISEMANN N
    Routine health data in skin cancer screening evaluation.
    Br J Dermatol. 2016;175:862.
    PubMed     Text format    


    Cancer

  4. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Cancer. 2017 Oct 12. doi: 10.1002/cncr.30946.
    PubMed     Text format     Abstract available


    Cancer Res

  5. COUNTER CM, Crowe MS, Greenberg DN, Brady DC, et al
    Copper Chelation Inhibits BRAFV600E-driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors.
    Cancer Res. 2017 Oct 6. pii: canres.1190.2016.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  6. CARRERA C, Scope A, Dusza SW, Argenziano G, et al
    Clinical and dermoscopic characterization of pediatric and childhood melanomas. Multicenter study of 52 cases.
    J Am Acad Dermatol. 2017 Oct 9. pii: S0190-9622(17)32475.
    PubMed     Text format     Abstract available

  7. SAFRAN T, Viezel-Mathieu A, Corban J, Kanevsky A, et al
    Machine Learning and Melanoma: The Future of Screening.
    J Am Acad Dermatol. 2017 Oct 5. pii: S0190-9622(17)32460.
    PubMed     Text format    


    J Clin Invest

  8. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    PubMed     Text format     Abstract available

  9. AYERS M, Lunceford J, Nebozhyn M, Murphy E, et al
    IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade.
    J Clin Invest. 2017;127:2930-2940.
    PubMed     Text format     Abstract available


    J Clin Oncol

  10. LONG GV, Eroglu Z, Infante J, Patel S, et al
    Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.
    J Clin Oncol. 2017 Oct 9:JCO2017741025. doi: 10.1200/JCO.2017.74.1025.
    PubMed     Text format     Abstract available


    Melanoma Res

  11. UPRETY D, Bista A, Chennamadhavuni A, Niroula A, et al
    Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study.
    Melanoma Res. 2017 Oct 11. doi: 10.1097/CMR.0000000000000394.
    PubMed     Text format     Abstract available

  12. FAILING JJ, Yan Y, Porrata LF, Markovic SN, et al
    Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients.
    Melanoma Res. 2017 Oct 9. doi: 10.1097/CMR.0000000000000404.
    PubMed     Text format     Abstract available

  13. SHEN X, Fan Y, Cao S
    A review of primary malignant melanoma arising in an ovarian cystic teratoma.
    Melanoma Res. 2017 Oct 9. doi: 10.1097/CMR.0000000000000402.
    PubMed     Text format     Abstract available


    Oncogene

  14. GELATO KA, Schockel L, Klingbeil O, Ruckert T, et al
    Super-enhancers define a proliferative PGC-1alpha-expressing melanoma subgroup sensitive to BET inhibition.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  15. MAURUS K, Hufnagel A, Geiger F, Graf S, et al
    The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Oncogene. 2017;36:5110-5121.
    PubMed     Text format     Abstract available

  16. LI Y, Zhou T, Wang Y, Ning C, et al
    The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
    Oncogene. 2017;36:3760-3771.
    PubMed     Text format     Abstract available


    PLoS One

  17. JASINSKA-KONIOR K, Pochylczuk K, Czajka E, Michalik M, et al
    Proton beam irradiation inhibits the migration of melanoma cells.
    PLoS One. 2017;12:e0186002.
    PubMed     Text format     Abstract available

  18. TERMINI JM, Gupta S, Raffa FN, Guirado E, et al
    Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.
    PLoS One. 2017;12:e0184915.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: